New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cabaletta Bio, Inc.
CABA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

191M

Biotechnology

Next Earning date - 14 Nov 2024

191M

Biotechnology

Next Earning date - 14 Nov 2024

3.91USD
Shape0.06 ( 1.43%)
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

-17%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

85%

Quote Panel

Shape
Updated October 26, 2024
1W -13.50 % 1M -8.22 % 3M -44.77 % 1Y -69.45 %

Key Metrics

Shape
  • Market Cap

    191.00M


  • Shares Outstanding

    48.85M


  • Share in Float

    41.14M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    3.91


  • Average Volume

    1.03M


  • Beta

    2.387


  • Range

    3.471-26.35


  • Industry

    Biotechnology


  • Website

    https://www.cabalettabio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

47.63x

P/S Ratio

0.97x

P/B Ratio

0.0

Debt/Equity

-2244.0%

Net Margin

$-1.9

EPS

How CABA compares to sector?

P/E Ratio

Relative Strength

Shape

CABA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$6M

ShapeNaN%

2025-Revenue

$2.40

Shape-328%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

UBS

initialise

Previous: Not converted

2024-10-10

Now: Buy

Guggenheim

initialise

Previous: Not converted

2023-07-18

Now: Buy

Morgan Stanley

downgrade

Previous: Not converted

2022-08-30

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.39
vs -0.45

Q4.22

arrow
arrow

N/A

-0.52
vs -0.49

Q1.23

arrow
arrow

N/A

-0.45
vs -0.45

Q2.23

arrow
arrow

N/A

-0.37
vs -0.45

Q3.23

arrow
arrow

N/A

-0.37
vs -0.39

Q4.23

arrow
arrow

N/A

-0.46
vs -0.52

Q1.24

arrow
arrow

N/A

-0.51
vs -0.45

Q2.24

arrow
arrow

N/A

-0.56
vs -0.37

Q3.24

arrow
arrow

N/A

-0.60
vs -0.37

Q4.24

arrow
arrow

N/A

-0.59
vs -0.46

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

4M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-13%

-0.13
vs -0.13

Q4.22

arrow
arrow

-14%

-0.14
vs -0.13

Q1.23

arrow
arrow

-16%

-0.16
vs -0.14

Q2.23

arrow
arrow

-8%

-0.08
vs -0.16

Q3.23

arrow
arrow

-10%

-0.10
vs -0.08

Q4.23

arrow
arrow

-9%

-0.09
vs -0.10

Q1.24

arrow
arrow

-11%

-0.11
vs -0.09

Q2.24

arrow
arrow

-14%

-0.14
vs -0.11

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

48

48
vs 47

2%

Q4.22

arrow
arrow

64

64
vs 48

33%

Q1.23

arrow
arrow

74

74
vs 64

16%

Q2.23

arrow
arrow

88

88
vs 74

19%

Q3.23

arrow
arrow

101

101
vs 88

15%

Q4.23

arrow
arrow

136

136
vs 101

35%

Q1.24

arrow
arrow

167

167
vs 136

23%

Q2.24

arrow
arrow

142

142
vs 167

-15%

Earnings Growth

Latest News